Ulcère du Buruli

1) Pouillot R, Matias G, Wondje CM, Portaels F, Valin N, Ngos F, Njikap A, Marsollier L, Fontanet A, Eyangoh S. Risk factors for buruli ulcer: a case control study in cameroon.
PLoS Negl Trop Dis.2007 Dec 19;1(3):e101.
PMID: 18160977. Abstract.
2) Chauty A, Ardant MF, Marsollier L, Pluschke G, Landier J, Adeye A, Goundoté A, Cottin J, Ladikpo T, Ruf T, Ji B.Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clin Infect Dis. 2011 Jan;52(1):94-6. Abstract
3) Marion E, Eyangoh S, Yeramian E, Doannio J, Landier J, Aubry J, Fontanet A, Rogier C, Cassisa V, Cottin J, Marot A, Eveillard M, Kamdem Y, Legras P, Deshayes C, Saint-André JP, Marsollier L.Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis. 2010 Jul 6;4(7):e731. Abstract
4) Marion E, Landier J, Boisier P, Marsollier L, Fontanet A, Le Gall P, Aubry J, Djeunga N, Umboock A, Eyangoh S. Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis ; 17(3): 551-3. Abstract
5) Vignier Guenin-Macé L, Carrette F, Asperti-Boursin F, Le Bon A, Caleechurn L, Di Bartolo V, Fontanet A, Bismuth G, Demangel C. Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12833-8. Epub 2011 Jul 18.. Abstract